Molecular Biomarkers & Diagnosis

Department of Cardiology, Hebrew University Jerusalem, Jerusalem 9574409, Israel

Publications

• Mini Review   
  Emerging Perspectives: Harnessing Clinical Biomarkers for Predicting Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer
  Author(s): Melina Gracia*
  
  Cardiotoxicity induced by systemic therapy poses a significant concern in the management of breast cancer, particularly in women undergoing treatment. The ability to predict and mitigate the risk of cardiotoxicity is crucial for improving patient outcomes and quality of life. In recent years, there has been a growing interest in harnessing clinical biomarkers as potential predictors of systemic therapy-induced cardiotoxicity. This review explores the emerging perspectives and advancements in utilizing clinical biomarkers to identify women with breast cancer who are at a higher risk of developing cardiotoxicity during systemic therapy. A comprehensive analysis of recent studies and clinical trials is presented, focusing on the evaluation and validation of various biomarkers, including but not limited to cardiac troponins, natriuretic peptides, imaging modalities, an.. Read More»
  DOI: 10.37421/2155-9929.2023.14.582

  Abstract HTML PDF